| Literature DB >> 27824140 |
Natalia Guschinskaya1,2,3, Romain Brunel1,2, Maxime Tourte3,4, Gina L Lipscomb5, Michael W W Adams5, Philippe Oger3,4, Xavier Charpentier1,2.
Abstract
Transposition mutagenesis is a powerful tool to identify the function of genes, reveal essential genes and generally to unravel the genetic basis of living organisms. However, transposon-mediated mutagenesis has only been successfully applied to a limited number of archaeal species and has never been reported in Thermococcales. Here, we report random insertion mutagenesis in the hyperthermophilic archaeon Pyrococcus furiosus. The strategy takes advantage of the natural transformability of derivatives of the P. furiosus COM1 strain and of in vitro Mariner-based transposition. A transposon bearing a genetic marker is randomly transposed in vitro in genomic DNA that is then used for natural transformation of P. furiosus. A small-scale transposition reaction routinely generates several hundred and up to two thousands transformants. Southern analysis and sequencing showed that the obtained mutants contain a single and random genomic insertion. Polyploidy has been reported in Thermococcales and P. furiosus is suspected of being polyploid. Yet, about half of the mutants obtained on the first selection are homozygous for the transposon insertion. Two rounds of isolation on selective medium were sufficient to obtain gene conversion in initially heterozygous mutants. This transposition mutagenesis strategy will greatly facilitate functional exploration of the Thermococcales genomes.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27824140 PMCID: PMC5099854 DOI: 10.1038/srep36711
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Growth and transformation conditions of P. furiosus COM1.
(A) Plating efficiencies using glass beads, plastic spreader and spotting at two temperatures of incubation (80 °C and 98 °C). Error bars indicate standart deviation from the mean of three independent experiments. (B) Transformation frequencies as a function of pH using flanking regions of 1500 bp. Transformation reactions contained 2 μg DNA per 1 ml of culture. 100 μl or 200 μl of cell culture (108 cells/ml) were respectively mixed with 200 ng or 400 ng of DNA. The transformation frequencies are calculated as the ratio of CFUs on selective medium (without uracil) divided by CFUs on non-selective medium (with uracil) per μg of DNA. Error bars represent standard deviation from the mean of eight independent experiments. (C) Transformation frequencies as a function of growth phase. Growth was monitored every two hours for 24 hours. Cells collected from a culture at time corresponding to exponential growth (4 h), mid-log (8 h), post-exponential (12 h) and stationary phase (24 h) were used for transformation in the same conditions as in panel B. Errors represent standard deviation from the mean of three technical replicates. (D) Transformation frequencies as a function of the size of the homologous flanking regions. Frequencies have been normalised to the copy number of the pyrF gene. Error bars indicate standart deviation from the mean of five independent experiments.
Figure 2In vitro transposition of mariner-based vector containing the Pgdh-pyrF cassette into genomic DNA using the MarC9 transposase.
(A) General strategy for the creation of a P. furiosus mutant library using in vitro transposition mutagenesis. The transposase MarC9 (dark green circles) recognises the IRL/IRR sites (in red) at the borders of Pgdh-pyrF cassette (carried by the pNG-Tn-pyrF plasmid) and transposes it by a cut-and-paste mechanism into genomic DNA (gDNA). Transposed gDNA is repaired using T4 DNA polymerase and E. coli DNA ligase and used to transform the uracil and trytophan auxotroph JFW02. (B) Agarose gel electrophoresis of the in vitro transposition reaction. Lane 1, transposon donor plasmid pGN-Tn-pyrF alone; lane 2, genomic DNA of strain JFW002 alone; lane 3, transposition reaction containing genomic DNA, donor plasmid pGN-Tn-pyrF and MarC9 transposase. Excision of the transposon from the transposon-donor plasmid pNG-Tn-pyrF can be evidenced by the appearance of a band at the size of the linear plasmid lacking the transposon (N, nicked plasmid; L, linear plasmid; B, backbone plasmid with transposon excised; SC, supercoiled plasmid). (C) Transformation frequencies of P. furiosus JFW002 transformed with in vitro transposed gDNA. Error bars represent standard deviation from the mean of four independent experiments. (D) Example of a transformation reaction with gDNA plated on a selective plate of minimal medium and incubated 5 days at 80 °C.
Figure 3Identification and dynamics of transposon insertions in the genome of P. furiosus JFW002.
(A) Southern blot analysis of 12 isolated and purified mutants probed with the pyrF gene. Lanes 1–12: purified randomly selected transposon insertion mutants; pNG-Tn-pyrF: positive control; JFW002: negative control. (B) COM1 genome distribution of the transposon insertions. Gene names (PFxxxx) according to the gene nomenclature for P. furiosus DSM 3638. (C) Typical gene conversion dynamics of transposon insertions monitored by PCR (known insertion). Due to meroploidy, all genomes of the mutant cells may not contain a mutated allele (red arrow, mutated allele; green arrow, wild-type allele). Conversion may require up to three successive subcultures in liquid selective medium. (D) Conversion dynamics of a pool of mutants assessed by plating on minimal medium with or without uracil. Mutants in which gene conversion is incomplete could generate uracil-auxotrophic progeny when plated on non-selective medium (ura+). A ratio of 100% ura+ CFU and ura− CFU indicates that all genomes copies of cells contain the pyrF transposon.
Positions of transposon insertion in the genome of P. furiosus COM1, with corresponding genes, proteins and their annotation.
| 1 | 116279 | PF0300 | AFN03089.1 | hypothetical protein GTP: adenosyl-cobinamide-phosphate guanylyltransferase |
| 2 | 869063 | PF1118 | AFN03909.1 | CRISPR-associated protein Cas1 |
| 3 | 216315 | PF0407 | AFN03198.1 | hypothetical protein |
| 4 | 1200285 | PF1504 | AFN04287.1 | large helicase-like protein COG1201 Lhr-like helicases |
| 5 | 1770485 | PF1756 | AFN04884.1 | hypothetical protein COG0393 Uncharacterized conserved protein |
| 6 | 775060 | PF1016 | AFN03812.1 | 2-hydroxyhepta-2,4-diene-1,7-dioate isomerase |
| 7 | 482399 | PF0669 | AFN03462.1 | hypothetical protein COG0454 Histone acetyltransferase HPA2 and related acetyltransferases |
| 8 | 811244 | PF1055 | AFN03851.1 | threonine synthase |
| 9 | 1526411 | PF2033 | AFN04610.1 | hypothetical protein predicted Fe-S oxidoreductase of SAM family |
| 10 | 737427 | PF0978 | AFN03773.1 | hypothetical protein COG1800 Predicted transglutaminase-like proteases |
| 11 | 982898 | PF1245 | AFN04032.1 | d-nopaline dehydrogenase COG0446 Uncharacterized NAD(FAD)-dependent dehydrogenases |
| 12 | 1489490 | PF0006 | AFN04032.1 | ABC transporter COG1131 ABC-type multidrug transport system, ATPase component |
*The corresponding gene loci numbers from the wild-type DSM 3638 strain are presented for convenience.